SCHEMBL594176

SCHEMBL594176

CCCCCCCCCCCC(=O)NC(C)O

nearest known ligand 0.74

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.74
MEN1 O00255 2/20 0.74
KMT2A Q03164 2/20 0.74
MAPK1 P28482 1/20 0.74
DNM1 Q05193 1/20 0.59
HSP90AA1 P07900 1/20 0.57
ASAH2 Q9NR71 1/20 0.57
ALDH1A1 P00352 1/20 0.55
ASAH1 Q13510 1/20 0.55
ACER2 Q5QJU3 1/20 0.55
NOD1 Q9Y239 1/20 0.54
PLA2G2C Q5R387 1/20 0.54
PLA2G10 O15496 2/20 0.54
THRB P10828 1/20 0.50
CETP P11597 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL308645 1.00 FAAH (0.74) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL16389868 1.00 FAAH (0.74) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL15281949 1.00 FAAH (0.74) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL10600706 1.00 FAAH (0.74) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL875221 1.00 FAAH (0.74) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL8627798 1.00 FAAH (0.74) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL308262 1.00 FAAH (0.74) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL8623658 1.00 FAAH (0.74) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL308684 1.00 FAAH (0.74) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL240206 1.00 FAAH (0.74) FAAHMEN1KMT2AMAPK1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115403882-B Biological simulation material formed by foaming process and preparation method and application thereof 中新巨成医学科技有限公司 2023-09-12 CN claimed
CN-105733348-A Inorganic ink cleaning agent 淄博市新材料研究所 2016-07-06 CN claimed
US-7199082-B1 Composition of an N-acylethanolamine plant hormone of an auxin, a gibberellin or a cytokinin; and a horticulturally-acceptable vehicle; treating and storing cut flowers, Christmas trees, fruits, and other severed plant parts UNIVERSITY OF NORTH TEXAS (US) 2007-04-03 US claimed
EP-1263286-B1 METHODS FOR EXTENDING THE FRESHNESS OF CUT FLOWERS UNIV NORTH TEXAS (US) 2006-02-22 EP claimed
EP-0122151-B1 PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE MEITO SANGYO KABUSHIKI KAISHA (JP) 1989-02-15 EP claimed
CN-117981524-A Application of N-lauroyl ethanolamine in promoting paris polyphylla seed embryo after-ripening and germination 云南中医药大学 2024-05-07 CN disclosed
US-11964043-B2 Method of emulsification using core-corona type microparticles SHISEIDO COMPANY, LTD. (JP) 2024-04-23 US disclosed
WO-2024059119-A2 COMPOUNDS AND THEIR USE IN FILTERING ULTRAVIOLET AND/OR HIGH-ENERGY VISIBLE LIGHT SOLIOME, INC. (US) 2024-03-21 WO disclosed
US-11931448-B2 Water-in-oil type emulsion composition SHISEIDO COMPANY, LTD. (JP) 2024-03-19 US disclosed
EP-4301790-A1 SUNSCREENS DERIVED FROM KYNURENINES AND OTHER UV-ABSORBING OXIDIZED AMINO ACIDS BOUND TO PEPTIDES OR POLYMERS The Trustees Of Princeton University (US) 2024-01-10 EP disclosed
EP-3520772-B1 COSMETIC RAW MATERIAL USING CORE-CORONA TYPE MICROPARTICLES AND OIL-IN-WATER TYPE EMULSION COSMETIC SHISEIDO CO LTD (JP) 2023-12-20 EP disclosed
WO-2023069956-A1 SILK STIMULATED COLLAGEN AND CLAUDIN-1 EXPRESSION, AND SILK STIMULATED ANTI-INFLAMMATORY EFFECTS EVOLVED BY NATURE, INC. (US) 2023-04-27 WO disclosed
US-20020041889-A1 ENHANCING AGENT FOR DEGRADATION OF DESMOSOMES OR STRATUM CORNEUM DESQUAMATION SHISEIDO COMPANY, LTD. (JP) 2002-04-11 US disclosed
EP-1153602-A1 SKIN PREPARATIONS FOR EXTERNAL USE SHISEIDO COMPANY LIMITED (JP) 2001-11-14 EP disclosed
US-5849651-A Reversible thermal recording medium KABUSHIKI KAISHA TOSHIBA (JP) 1998-12-15 US disclosed
EP-0852949-A2 Use of alpha-amino-acids for enhancing desmosomal degradation or stratum corneum desquamation SHISEIDO COMPANY LIMITED (JP) 1998-07-15 EP disclosed
EP-0815838-A2 External skin treatment composition SHISEIDO COMPANY, LTD. (JP) 1998-01-07 EP disclosed
US-5663115-A COLORFORMER AND DEVELOPER FOR HEAT SENSITIVE ELEMENTS KABUSHIKI KAISHA TOSHIBA (JP) 1997-09-02 US disclosed
EP-0723004-A1 DETERGENT COMPOSITION Kao Corporation (JP) 1996-07-24 EP disclosed
US-4124523-A POLYDIMETHYLSILOXANE, ABRASIVES, COLLOIDAL SILICA DOW CORNING CORPORATION (US) 1978-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020041889-A1 ENHANCING AGENT FOR DEGRADATION OF DESMOSOMES OR STRATUM CORNEUM DESQUAMATION DSG1, DSC1, CUTA FAAH 233/4885MEN1 2165/4885KMT2A 4416/4885
US-11964043-B2 Method of emulsification using core-corona type microparticles LIPA, CORO1A, CLTA FAAH 184/4885MEN1 3818/4885KMT2A 3181/4885
US-11931448-B2 Water-in-oil type emulsion composition FAM83A, LIPA, CUTA FAAH 913/4885MEN1 4025/4885KMT2A 1990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.